Research on how bacteria evade antibiotics. Covers adaptive metabolism, water-source resistance, drug-efflux pumps, and microplastic pollutant shuttles.
A new study suggests that sevelamer, a FDA-approved dialysis drug, can remove off-target antibiotics from the gut in mice. This could potentially prevent antibiotic resistance from emerging and protect current antibiotics from becoming ineffective.
Researchers found that curcumin enhances the effectiveness of bedaquiline in combating M. abscessus infections, with the combination showing synergistic enhancement of antibacterial activity. The study suggests potential new treatment pathways for resistant infections, particularly in immunocompromised populations.
Researchers found that lower doses (20mg) and higher doses (100mg) of doxycycline were equally effective in treating lymphocytic scarring alopecia, a rare skin condition causing permanent hair loss. The low-dose regimen resulted in fewer side effects and no compromise on efficacy or anti-inflammatory benefit.
A new study using a microfluidic device found that certain infections may not be as resistant to antibiotics as previously thought. The researchers tested three different antibiotic agents against Pseudomonas aeruginosa and found a gradient of antibiotic activity dependent on the flow rate.
A recent study has discovered that microplastics can facilitate the development of antimicrobial resistance in bacteria, even in the absence of antibiotics. The researchers used different types and sizes of plastic to expose E. coli bacteria to various antibiotics and found significant increases in multidrug resistance after exposure.
A new study from Weizmann Institute of Science reveals an immune mechanism involving proteasome products, which can kill bacteria and offer a promising treatment for infections. The researchers discovered that certain peptides produced by the proteasome have antibacterial properties and can be used to develop personalized treatments.
Professor Robert T. Schooley will present a talk at the 8th World Congress on Targeting Phage Therapy, exploring phage therapy advancements and necessary steps for widespread adoption. The congress will gather experts to discuss latest advances, challenges, and clinical applications of bacteriophage therapy.
A novel therapeutic strategy for superbug infections has been discovered using the siRNA-AGO2 complex. This complex inhibits bacterial gene translation by delivering AGO2-loaded siRNA into bacterial cytoplasm, downregulating resistance genes and converting multidrug-resistant bacteria into methicillin-sensitive ones.
A study found that soil bacterial communities show increased antimicrobial resistance due to the presence of a predatory bacterium, Myxococcus xanthus. The researchers suggest that exposure to growth-inhibitory molecules released by M. xanthus leads to the enrichment of resistant isolates.
A groundbreaking study has identified a dual-target approach that significantly prevents the development of resistance in bacteria. This approach combines membrane disruption with an additional critical cellular pathway, offering a potential solution to mitigate the escalating threat of antimicrobial resistance.
A new method for detecting antibiotic resistance genes (ARGs) in wastewater has been developed by researchers, which uses CRISPR-Cas9 technology to enrich ARG fragments and increase detection sensitivity. This enhanced method was found to detect 1189 more ARGs and 61 more ARG families compared to standard metagenomics methods.
Researchers from the University of Surrey found that a balance between reactive nitrogen species and reactive oxygen species affects drug-resistant bacteria. The study suggests treatments boosting reactive nitrogen species may be effective against antibiotic-resistant bacteria.
A new study published in the Journal of Antimicrobial Chemotherapy has found that lenacapavir is effective in controlling HIV in a population of patients in Uganda. The study sequenced the capsid proteins from 546 Ugandan patients and found little natural resistance to the drug.
A study found that even with impeccable cleaning, hospital sink drains can host bacterial populations that change over time. Dominant species include Stenotrophomonas and Pseudomonas aeruginosa, known to cause ventilator-associated pneumonia and sepsis.
A team of scientists has developed a cutting-edge technology to analyze bacterial sexually transmitted infections (STIs) using genome sequencing. The 'target enrichment' method enables high-resolution analysis of Chlamydia trachomatis and other pathogens, revealing new insights into their transmission and development pathways.
Researchers found that people with diabetes are more likely to develop antibiotic-resistant strains of Staphylococcus aureus, which can spread rapidly and evade treatment. Controlling blood sugar levels through insulin use may be key in preventing antibiotic resistance.
Researchers at San Francisco State University have developed a step-by-step machine learning tutorial to detect antibiotic resistance in patients. The team used a publicly available dataset to train four popular machine learning models, which can be easily accessed through Google Colab. The tutorial aims to make machine learning access...
Researchers at Texas A&M University have developed a low-cost technology using curcumin to curb bacterial resistance. The study shows that photodynamic inactivation can trigger deleterious reactions within bacteria, killing them and reducing the number of antibiotic-resistant strains.
Researchers from the University of Basel challenged the idea that persisters are responsible for antibiotic ineffectiveness. They found that nutrient starvation increases Salmonella resilience, making antibiotics less effective. This discovery could lead to more effective therapies against difficult-to-treat infections.
Researchers at UCSF have discovered how a unique type of virus called a jumbo phage protects itself inside bacteria. The shield works via a set of secret handshakes that allow only useful proteins to pass through, giving the phage an advantage over regular phages when fighting infections.
A new genomic toolkit called Sphae has been developed to quickly assess the suitability of phage therapy for treating antibiotic-resistant bacterial strains. The platform can analyze vast datasets in under 10 minutes, prioritizing safety and flagging genes associated with toxins or undesirable traits.
Carbapenem-resistant Enterobacterales, including K. pneumoniae and E. coli, pose a significant risk to EU/EEA patients and healthcare systems. The epidemiological situation has deteriorated since 2019, with high-risk lineages spreading in hospitals.
Recent studies have found that new antibiotics are prone to rapid development of resistance, even before they are widely used. This raises concerns about the effectiveness of these treatments in the long run. To address this issue, researchers call for a shift in antibiotic development prioritizing novel modes of action and responsible...
Researchers identified a unique genetic signature that can predict bacterial antibiotic resistance. The finding could help develop precision-based treatments and reduce overuse of antibiotics.
Researchers discovered a mechanism involving protein aggregation that allows bacteria to enter a dormant state, making them resistant to antibiotics. The study also found that protein aggregates can promote bacterial survival in stressful environments.
A new compound, V-161, has been discovered to effectively inhibit the growth of vancomycin-resistant Enterococci (VRE) by targeting a crucial enzyme. The study reveals that V-161 not only disrupts the enzyme function but also reduces VRE colonization in the mouse small intestine.
Researchers have discovered a complex mechanism that allows bacteria to build resistance to antibiotics, involving a KorB-KorA regulatory system. This finding offers a fresh insight into long-range gene silencing in bacteria and provides a potential target for novel therapeutics.
Researchers found that short-course antibiotics can be as effective as traditional longer treatments in preventing death and recurrence of pneumonia. This approach offers significant value for healthcare systems by reducing hospital expenditure while maintaining excellent patient outcomes.
Researchers at UVA have developed computer models to target specific bacteria in specific parts of the body, reducing the chance of antibiotic resistance. This approach could lead to more effective treatments and reduce the need for broad-spectrum antibiotics.
A large UK trial found that adding procalcitonin (PCT) to routine care did not reduce IV antibiotic use in hospitalized children. The study, part of the BATCH trial, enrolled nearly 2,000 children and tested PCT's effectiveness in guiding treatment decisions.
The University of Arizona College of Medicine – Tucson laboratory is working on discovering new ways to neutralize harmful microorganisms using copper. The researchers aim to understand how copper kills bacteria by flooding their environment with excess copper, tricking them into building essential proteins with the wrong materials.
Researchers found that a person's microbiome signature can predict the likelihood of Enterobacteriaceae colonization. Fiber-rich foods support the growth of beneficial Faecalibacterium, which produce short-chain fatty acids protecting against infection.
A groundbreaking UK study found that using procalcitonin (PCT) to guide treatment decisions did not reduce antibiotic duration in hospitalized children. The PCT test was safe but costlier than standard methods, and healthcare teams faced challenges integrating it into their decision-making processes.
A recent study found that multidrug-resistant Klebsiella pneumoniae exhibits distinct characteristics in Saudi Arabia, with molecular factors contributing to increased virulence and severity. The researchers highlight the need for tailored surveillance programs and new antimicrobial agents to address this local threat.
Researchers at Salk Institute discovered plant cells enter an immune state to fight pathogens, using Primary IMmunE Responder (PRIMER) cells as hubs for the immune response. These cells are surrounded by bystander cells that enable long-distance cell-to-cell communication.
Researchers developed an AI tool, AMR-Policy GPT, to bridge knowledge gaps in antimicrobial resistance policy development. The tool provides well-referenced information for policymakers, increasing global knowledge-sharing and contextually relevant data.
The rollout of doxycycline as a prevention strategy for sexually transmitted infections (STIs) has shown promise in reducing syphilis and chlamydia rates, but its effectiveness on gonorrhea is limited. Close monitoring for antimicrobial resistance is necessary to ensure the long-term efficacy of doxy PEP.
A new study reveals that anti-defense genes near the DNA entry point enable plasmids to overcome CRISPR system, promoting genetic transfer between bacteria. This discovery could pave the way for developing tools to address antibiotic resistance and genetic manipulation methods.
Researchers found unique signatures in household plumbing microbiomes, with wide variation from house to house. They also detected antibiotic resistance genes, highlighting the need for better monitoring and prevention strategies.
Researchers found that soil contains antibiotic resistance genes that can be transmitted to humans, making it a pressing public health threat. The study reveals how these genes spread through the environment and highlights the importance of understanding soil ecosystems to control antibiotic resistance.
A recent study found a significant increase in severe multidrug-resistant Shigella sonnei infections among people experiencing homelessness (PEH) in Vancouver. The strain, genotype 3.6.1.2, is resistant to nearly all antibiotics, leading to higher hospitalization rates and more severe outcomes.
Researchers at IBEC are developing Phagocytic Synthetic Cells (PSCs) to target antibiotic-resistant pathogens. The innovative cells use programmable membranes to eliminate harmful bacteria, offering a potential solution to the growing antimicrobial resistance crisis.
Researchers found that bacteria like E. coli assemble new ribosomes with altered tags, making them more resistant to antibiotics streptomycin and kasugamycin. This novel mechanism of antibiotic resistance could have significant implications for the fight against global antimicrobial resistance.
Researchers found pandrug-resistant Klebsiella pneumoniae in Ukrainian war victims, showing high virulence and rapid spread. The bacteria's ability to cause disease remains despite antibiotic resistance.
Researchers developed an artificial intelligence model that selects the best phage cocktail for a given patient based on their genome. The model was tested on a new collection of E. coli strains responsible for pneumonia and showed high success rates.
Antimicrobial resistance is a growing threat in Detroit, requiring immediate attention from the community. Health experts recommend educating oneself about responsible antibiotic use and adopting practices such as hand hygiene and vaccination.
Two studies found that multidrug-resistant Enterobacterales, particularly Escherichia coli ST131 and Providencia stuartii NDM-1, are spreading in healthcare and community settings across Europe. The emergence of these resistant bacteria poses a significant threat to carbapenem treatment effectiveness.
Researchers at the University of Liverpool used AI to develop a personalised method for treating urinary tract infections, improving accuracy and reducing antibiotic resistance. The new approach uses real-time data to target specific bacterial infections, making antibiotics more effective.
Researchers have demonstrated a potential antibacterial treatment from a modified darobactin against infections caused by bacteria such as E. coli and Acinetobacter baumannii, which are known to develop drug resistance. The compound D22 showed efficacy in animal trials, highlighting its promise for further development.
Antibiotic consumption in the EU increased by 1% between 2019 and 2023, moving further away from the 2030 target of a 20% reduction. Despite significant reductions in methicillin-resistant Staphylococcus aureus bloodstream infections, carbapenem-resistant Klebsiella pneumoniae bloodstream infections worsened, with an increase in incide...
A study from Umea University reveals that nanoplastics can absorb and accumulate antibiotics, reducing their targeted effect and risking the emergence of antibiotic-resistant bacteria. The researchers found a strong bond between nylon nanoplastics and tetracycline, a common broad-spectrum antibiotic.
A new study reveals dramatic changes to gut and mouth bacteria in people with chronic liver disease, correlating with increased antibiotic resistance and poor clinical outcomes. The findings suggest a need for personalized microbiome-based treatments and rapid diagnosis of infections to improve patient care.
Scientists have discovered a weakness in antibiotic-resistant bacteria that can be exploited to stop the spread of this public health crisis. By understanding the link between magnesium limitation and ribosome variants, researchers may develop novel drug-free approaches to combat antibiotic resistance.
World health leaders converge on QF's WISH 2024 to stress the gravity of antimicrobial resistance, highlighting global actions needed to preserve antibiotic efficacy. Effective strategies and collaborative efforts are crucial to addressing this pressing issue and safeguarding public health.
A $3.96 million grant will support the development of a monitoring device and data-processing algorithm to guide combination therapy design against multidrug-resistant bacteria. The goal is to overcome bacterial defenses and combat the emergence of resistance.
Researchers found that a chlorine-cocoa butter mixture can effectively treat diseased corals, reducing tissue loss and environmental harm. The alternative approach offers a cheaper, biodegradable solution to combat antibiotic-resistant bacteria.
The Qatar Foundation's WISH 2024 Summit focused on global health challenges in times of conflict, highlighting the need for innovative solutions to ensure equitable access to healthcare. Key discussions centered around protecting healthcare personnel and infrastructure during armed conflicts and addressing antimicrobial resistance.
Researchers have uncovered why a relatively new antibiotic for tuberculosis works against multidrug-resistant strains by identifying deficiencies in a critical enzyme. This discovery could lead to improved treatments and drug development strategies, potentially allowing for lower doses or shorter treatment times.
A multidrug-resistant strain of Klebsiella pneumoniae has been detected in Northeast Brazil, with the bacterium being resistant to all available antibiotics. The strain had previously been detected in the US and can potentially spread globally.
The winners of the Applied Microbiology International Horizon Awards 2024 have been named, including the One Health Microbiome Center at Penn State and researchers Dr. François Thomas and Dr. Helen Onyeaka.